PDS BIOTECHNOLOGY CORP (PDSB) Top Institutional Shareholders

PDS BIOTECHNOLOGY CORP (PDSB) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $3.05M in PDSB holdings during the latest filing period.

Vanguard Capital Management Llc is currently the largest disclosed institutional shareholder of PDSB tracked by InsiderSet, reporting ownership valued at approximately $986,809 in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $1.48M, representing an estimated gain of +50.25% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 85% of the total disclosed PDSB value among the investors covered in this analysis. Major shareholders include Vanguard Capital Management Llc, Geode Capital Management, Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in PDS BIOTECHNOLOGY CORP (PDSB).

This page ranks the largest institutional PDSB shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

38

Total Reported Value

$3.05M

Largest Holder

Vanguard Capital Management Llc

Largest Position

$986,809

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

50

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Vanguard Capital Management Llc0.00%1,631,089$986,809$1,482,660+$495,851+50.25%
Geode Capital Management, Llc0.00%660,228$399,489$600,147+$200,658+50.23%
Blackrock, Inc.0.00%554,048$335,199$503,630+$168,431+50.25%
Vanguard Fiduciary Trust Co0.00%307,311$185,923$279,346+$93,423+50.25%
Blair William & Co/Il0.00%300,000$181,500$272,700+$91,200+50.25%
Renaissance Technologies LLCJim Simons0.00%220,800$133,584$200,707+$67,123+50.25%
Inspirion Wealth Advisors, Llc0.01%181,995$110,107$165,433+$55,326+50.25%
Armistice Capital, Llc0.00%173,605$105,031$157,807+$52,776+50.25%
State Street Corp0.00%133,333$80,666$121,200+$40,534+50.25%
Wells Fargo & Company/Mn0.00%110,500$66,853$100,445+$33,592+50.25%
Northern Trust Corp0.00%108,893$65,880$98,984+$33,104+50.25%
Commonwealth Equity Services, Llc0.00%90,797$54,930$82,534+$27,604+50.25%
Iron Gate Global Advisors Llc0.00%75,022$45,388$68,195+$22,807+50.25%
Bank Of New York Mellon Corp0.00%69,311$41,934$63,004+$21,070+50.24%
Nine Masts Capital Ltd0.01%67,507$40,842$61,364+$20,522+50.25%
Tempus Wealth Planning, Llc0.01%61,800$37,389$56,176+$18,787+50.25%
Ubs Group Ag0.00%56,004$33,882$50,908+$17,026+50.25%
Xtx Topco Ltd0.00%36,211$21,908$32,916+$11,008+50.25%
Two Sigma Securities, Llc0.00%31,481$19,046$28,616+$9,570+50.25%
Act Capital Management, Llc0.01%30,000$18,150$27,270+$9,120+50.25%
Rockefeller Capital Management L.P.0.00%27,664$16,737$25,147+$8,410+50.25%
Susquehanna International Group, Llp0.00%22,052$13,341$20,045+$6,704+50.25%
Federation Des Caisses Desjardins Du Quebec0.00%14,800$8,954$13,453+$4,499+50.25%
Vanguard Global Advisers, Llc0.00%12,546$7,590$11,404+$3,814+50.25%
United Capital Financial Advisors, Llc0.00%12,000$7,260$10,908+$3,648+50.25%
Raymond James Financial Inc0.00%10,236$6,193$9,305+$3,112+50.24%
Davenport & Co Llc0.00%10,000$6,050$9,090+$3,040+50.25%
Grandfield & Dodd, Llc0.00%10,000$6,050$9,090+$3,040+50.25%
Morgan Stanley0.00%3,922$2,373$3,565+$1,192+50.24%
Group One Trading Llc0.00%3,567$2,158$3,242+$1,084+50.25%
Creative Financial Designs Inc0.00%3,000$1,815$2,727+$912+50.25%
Jones Financial Companies Lllp0.00%2,000$1,082$1,818+$736+68.02%
Truvestments Capital Llc0.00%655$396$595+$199+50.35%
Bnp Paribas Financial Markets0.00%648$392$589+$197+50.26%
Simplex Trading, Llc0.00%271$163$246+$83+51.13%
Sbi Securities Co., Ltd.0.00%118$71$107+$36+51.07%
Wealth Group, Ltd.0.01%13,399$8$12,180+$12,172+152146.14%
Beacon Investment Advisory Services, Inc.0.00%5$4$5+$1+13.62%

Frequently asked questions about PDSB

  • Who owns the most PDSB stock?

    The largest holders of PDSB are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for PDS BIOTECHNOLOGY CORP (PDSB).

  • Is PDSB widely held by superinvestors?

    Many widely followed stocks like PDSB appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly PDSB is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.